Alnylam Pharmaceuticals, Inc. (ALNY)
296.11
-13.38
(-4.32%)
USD |
NASDAQ |
May 01, 16:00
296.18
+0.07
(+0.02%)
Pre-Market: 20:00
Alnylam Pharmaceuticals Total Assets (Quarterly) : 5.130B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 116.58B |
| Pfizer Inc. | 208.16B |
| Aldeyra Therapeutics, Inc. | 72.06M |
| Ionis Pharmaceuticals, Inc. | 3.450B |
| Glaukos Corp. | 893.33M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.054B |
| Shareholders Equity (Quarterly) | 1.075B |
| Debt to Equity Ratio | 2.762 |
| Current Ratio | 3.127 |
| Net Debt Paydown Yield | -0.10% |